Insights

Innovative Biomarkers MiraDx specializes in microRNA-based genetic biomarkers that enable highly personalized cancer treatments, creating opportunities to collaborate with healthcare providers seeking advanced diagnostics for improved patient outcomes.

Recent Product Launch The recent launch of the PROSTOX ultra test positions MiraDx as a leader in predictive diagnostics for radiation therapy toxicity, opening avenues to partner with oncology clinics and radiation centers interested in reducing treatment complications.

Expanding Research Collaborations MiraDx’s active collaborations with academic institutions like UCLA and industry partners suggest potential for joint research initiatives or licensing arrangements to advance personalized cancer therapies.

Regulatory and Market Growth With the availability of breakthrough tests in the U.S. market and validation through peer-reviewed studies, MiraDx presents opportunities to expand into national and international markets focused on precision oncology solutions.

Targeted Oncology Market Focusing on prostate cancer and radiation therapy side effect prediction, MiraDx offers a compelling value proposition for oncology clinics and hospitals aiming to integrate cutting-edge diagnostics into standard care protocols.

MiraDx Tech Stack

MiraDx uses 8 technology products and services including Open Graph, oEmbed, Google Fonts API, and more. Explore MiraDx's tech stack below.

  • Open Graph
    Content Management System
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • GoDaddy
    Web Hosting
  • RankMath SEO
    Web Platform Extensions
  • Genesis Framework
    Web Platform Extensions

Media & News

MiraDx's Email Address Formats

MiraDx uses at least 1 format(s):
MiraDx Email FormatsExamplePercentage
First@miradx.comJohn@miradx.com
46%
FLast@miradx.comJDoe@miradx.com
4%
First@miradx.comJohn@miradx.com
46%
FLast@miradx.comJDoe@miradx.com
4%

Frequently Asked Questions

Where is MiraDx's headquarters located?

Minus sign iconPlus sign icon
MiraDx's main headquarters is located at 11601 Wilshire Boulevard 105 Los Angeles, California United States. The company has employees across 1 continents, including North America.

What is MiraDx's phone number?

Minus sign iconPlus sign icon
You can contact MiraDx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MiraDx's stock symbol?

Minus sign iconPlus sign icon
MiraDx is a publicly traded company; the company's stock symbol is LMDXW.

What is MiraDx's official website and social media links?

Minus sign iconPlus sign icon
MiraDx's official website is miradx.com and has social profiles on LinkedIn.

What is MiraDx's SIC code NAICS code?

Minus sign iconPlus sign icon
MiraDx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MiraDx have currently?

Minus sign iconPlus sign icon
As of March 2026, MiraDx has approximately 28 employees across 1 continents, including North America. Key team members include Chief Operating Officer: B. M.Vp Of Engineering: T. M.Owner: M. P.. Explore MiraDx's employee directory with LeadIQ.

What industry does MiraDx belong to?

Minus sign iconPlus sign icon
MiraDx operates in the Biotechnology Research industry.

What technology does MiraDx use?

Minus sign iconPlus sign icon
MiraDx's tech stack includes Open GraphoEmbedGoogle Fonts APIjQuery MigrateCloudflare Bot ManagementGoDaddyRankMath SEOGenesis Framework.

What is MiraDx's email format?

Minus sign iconPlus sign icon
MiraDx's email format typically follows the pattern of First@miradx.com. Find more MiraDx email formats with LeadIQ.

When was MiraDx founded?

Minus sign iconPlus sign icon
MiraDx was founded in 2010.

MiraDx

Biotechnology ResearchCalifornia, United States11-50 Employees

MiraDX was founded by Joanne Weidhaas, M.D., Ph.D. and Frank Slack, Ph.D., whose cutting-edge genetic research has unveiled a new class of genetic biomarkers, based on microRNA biology. Our mission is to apply these novel biomarkers to improve personalized cancer treatment. 
 
We have been applying these biomarkers to better direct cancer treatments, including radiation, chemotherapy, and newly developing immune therapies. We are able to apply our biomarkers to the daunting problem of toxicity from treatment, which no other set of biomarkers has been able to do.  

Through worldwide collaborations MiraDX has advanced this class of biomarkers to the forefront of personalized therapy, and has numerous collaborations across both academic and industry. We encourage you to learn more by visiting our website at MiraDX.com, as well as through visiting our sister non-profit, MiraKind, at MiraKind.org.

Section iconCompany Overview

Headquarters
11601 Wilshire Boulevard 105 Los Angeles, California United States
Phone number
Website
miradx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LMDXW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    MiraDx's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    MiraDx's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.